US2844579A
(en)
|
|
1958-07-22 |
|
Process for thiamine monomtrate |
US3180859A
(en)
|
1962-12-05 |
1965-04-27 |
Upjohn Co |
Derivatives of decoyinine and process for preparing same
|
US3431252A
(en)
|
1966-04-01 |
1969-03-04 |
Merck & Co Inc |
5,5-dialkyl-d-ribofuranosyl purine compounds and intermediates
|
US3480613A
(en)
|
1967-07-03 |
1969-11-25 |
Merck & Co Inc |
2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
|
GB1319303A
(en)
|
1970-07-14 |
1973-06-06 |
Univ Bradford |
Sugar derivatives
|
US3816399A
(en)
|
1970-07-14 |
1974-06-11 |
Univ Bradford |
1-amine nucleosides
|
US3872084A
(en)
|
1972-10-10 |
1975-03-18 |
Syntex Inc |
Purine nucleoside 3,5-cyclicphosphate compounds
|
US3872098A
(en)
|
1972-10-10 |
1975-03-18 |
Syntex Inc |
1,n{hu 6{b ethenoadenosine cyclophosphate compounds
|
US4093714A
(en)
|
1974-03-15 |
1978-06-06 |
Icn Pharmaceuticals, Inc. |
9β-D-Arabinofuranosylpurine nucleotides and method of use
|
PL144471B1
(en)
|
1985-04-22 |
1988-05-31 |
Polska Akad Nauk Centrum |
Method of obtaining novel 3',5'-cyclic adensine dithiophosphate
|
DE3689976T2
(de)
|
1985-05-15 |
1995-03-16 |
Wellcome Found |
Therapeutische Nucleoside und deren Herstellung.
|
AU8276187A
(en)
|
1986-10-31 |
1988-05-25 |
Warner-Lambert Company |
Selected n6-substituted adenosines having selective a2 binding activity
|
IL86007A0
(en)
|
1987-04-09 |
1988-09-30 |
Wellcome Found |
6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
|
DE8708526U1
(de)
|
1987-06-19 |
1987-08-27 |
REHAU AG + Co, 8673 Rehau |
Möbelfuß
|
US4885739A
(en)
|
1987-11-13 |
1989-12-05 |
Dsc Communications Corporation |
Interprocessor switching network
|
DE3824110A1
(de)
|
1988-07-15 |
1990-01-18 |
Max Planck Gesellschaft |
Verfahren zur herstellung und reinigung von an ihrem 5'-ende phosphorylierten oligo- und jpolynukleotidsequenzen und reagenz zur durchfuehrung des verfahrens
|
HUT51643A
(en)
|
1988-11-21 |
1990-05-28 |
Syntex Inc |
Process for producing antiviral agents and pharmaceutical compositions comprising same as active ingredient
|
DD279247A1
(de)
|
1989-01-01 |
1990-05-30 |
Akad Wissenschaften Ddr |
Verfahren zur herstellung von 1-beta-d-allofuranosylthyminnucleosiden
|
US5646128A
(en)
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
JPH0446124A
(ja)
|
1990-06-13 |
1992-02-17 |
Advance Co Ltd |
抗潰瘍剤
|
US5378825A
(en)
|
1990-07-27 |
1995-01-03 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
US6087482A
(en)
|
1990-07-27 |
2000-07-11 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
US5677437A
(en)
|
1990-07-27 |
1997-10-14 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
US5610289A
(en)
|
1990-07-27 |
1997-03-11 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogues
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
AU665184B2
(en)
|
1991-01-23 |
1995-12-21 |
Gensia, Inc. |
Adenosine kinase inhibitors
|
EP0586523A4
(en)
|
1991-05-15 |
1995-11-29 |
Univ Yale |
Determination of prodrugs metabolizable by the liver and therapeutic use thereof
|
IT1249732B
(it)
|
1991-11-26 |
1995-03-09 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso.
|
US6469158B1
(en)
|
1992-05-14 |
2002-10-22 |
Ribozyme Pharmaceuticals, Incorporated |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5977343A
(en)
|
1992-05-14 |
1999-11-02 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5686599A
(en)
|
1992-05-14 |
1997-11-11 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
US5714383A
(en)
|
1992-05-14 |
1998-02-03 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for treating chronic myelogenous leukemia
|
US5804683A
(en)
|
1992-05-14 |
1998-09-08 |
Ribozyme Pharmaceuticals, Inc. |
Deprotection of RNA with alkylamine
|
US5625056A
(en)
|
1992-05-26 |
1997-04-29 |
Biolog Life Science Institute |
Derivatives of cyclic guanosine-3',5'-monophosphorothioate
|
WO1993025566A1
(en)
|
1992-06-18 |
1993-12-23 |
Jyoti Chattopadhyaya |
Deuterated nucleosides
|
US5811300A
(en)
|
1992-12-07 |
1998-09-22 |
Ribozyme Pharmaceuticals, Inc. |
TNF-α ribozymes
|
US5658780A
(en)
|
1992-12-07 |
1997-08-19 |
Ribozyme Pharmaceuticals, Inc. |
Rel a targeted ribozymes
|
US5616488A
(en)
|
1992-12-07 |
1997-04-01 |
Ribozyme Pharmaceuticals, Inc. |
IL-5 targeted ribozymes
|
US5837542A
(en)
|
1992-12-07 |
1998-11-17 |
Ribozyme Pharmaceuticals, Inc. |
Intercellular adhesion molecule-1 (ICAM-1) ribozymes
|
JPH06228186A
(ja)
|
1993-01-29 |
1994-08-16 |
Yamasa Shoyu Co Ltd |
2’−デオキシ−(2’s)−アルキルピリミジンヌクレオシド誘導体
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
JPH08508490A
(ja)
|
1993-03-31 |
1996-09-10 |
スターリング ウィンスロップ インコーポレイティド |
新規5’−置換ヌクレオシド及びそれから得られるオリゴマー
|
WO1994022888A1
(en)
|
1993-03-31 |
1994-10-13 |
Sterlingwinthrop Inc. |
Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
|
GB9311682D0
(en)
|
1993-06-05 |
1993-07-21 |
Ciba Geigy Ag |
Chemical compounds
|
US5552311A
(en)
|
1993-09-14 |
1996-09-03 |
University Of Alabama At Birmingham Research Foundation |
Purine nucleoside phosphorylase gene therapy for human malignancy
|
US6017896A
(en)
|
1993-09-14 |
2000-01-25 |
University Of Alabama Research Foundation And Southern Research Institute |
Purine nucleoside phosphorylase gene therapy for human malignancy
|
US6491905B1
(en)
|
1993-09-14 |
2002-12-10 |
The Uab Research Foundation |
Recombinant bacterial cells for delivery of PNP to tumor cells
|
US6156501A
(en)
|
1993-10-26 |
2000-12-05 |
Affymetrix, Inc. |
Arrays of modified nucleic acid probes and methods of use
|
WO1995011910A1
(en)
|
1993-10-27 |
1995-05-04 |
Ribozyme Pharmaceuticals, Inc. |
2'-amido and 2'-peptido modified oligonucleotides
|
DE4341161A1
(de)
|
1993-12-02 |
1995-06-08 |
Michael Prof Dr Zeppezauer |
Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese
|
AU1436995A
(en)
|
1993-12-30 |
1995-07-17 |
Chemgenes Corporation |
Synthesis of propargyl modified nucleosides and phosphoramidites and their incorporation into defined sequence oligonucleotides
|
US5631359A
(en)
|
1994-10-11 |
1997-05-20 |
Ribozyme Pharmaceuticals, Inc. |
Hairpin ribozymes
|
US5639647A
(en)
|
1994-03-29 |
1997-06-17 |
Ribozyme Pharmaceuticals, Inc. |
2'-deoxy-2'alkylnucleotide containing nucleic acid
|
US5902880A
(en)
|
1994-08-19 |
1999-05-11 |
Ribozyme Pharmaceuticals, Inc. |
RNA polymerase III-based expression of therapeutic RNAs
|
US5693532A
(en)
|
1994-11-04 |
1997-12-02 |
Ribozyme Pharmaceuticals, Inc. |
Respiratory syncytial virus ribozymes
|
US6639061B1
(en)
|
1999-07-07 |
2003-10-28 |
Isis Pharmaceuticals, Inc. |
C3′-methylene hydrogen phosphonate oligomers and related compounds
|
US5871918A
(en)
|
1996-06-20 |
1999-02-16 |
The University Of North Carolina At Chapel Hill |
Electrochemical detection of nucleic acid hybridization
|
US5580967A
(en)
|
1994-05-13 |
1996-12-03 |
The Scripps Research Institute |
Optimized catalytic DNA-cleaving ribozymes
|
US6063566A
(en)
|
1994-05-13 |
2000-05-16 |
The Scripps Research Institute |
Catalytic RNA molecules
|
GB9417746D0
(en)
|
1994-09-03 |
1994-10-19 |
Ciba Geigy Ag |
Chemical compounds
|
GB9417938D0
(en)
|
1994-09-06 |
1994-10-26 |
Ciba Geigy Ag |
Compounds
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US7141665B1
(en)
|
1998-04-29 |
2006-11-28 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
US5807718A
(en)
|
1994-12-02 |
1998-09-15 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
ATE222765T1
(de)
|
1995-02-01 |
2002-09-15 |
Resprotect Gmbh |
Verwendung von 5' substituierten nukleosiden zur hemmung von resistenzbildung bei der zytostatikabehandlung
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
AU4931196A
(en)
|
1995-03-24 |
1996-10-16 |
Christian Noe |
Nucleic acid polyester polyamides
|
US6132971A
(en)
|
1995-06-27 |
2000-10-17 |
The University Of North Carolina At Chapel Hill |
Microelectronic device
|
US6361951B1
(en)
|
1995-06-27 |
2002-03-26 |
The University Of North Carolina At Chapel Hill |
Electrochemical detection of nucleic acid hybridization
|
US5968745A
(en)
|
1995-06-27 |
1999-10-19 |
The University Of North Carolina At Chapel Hill |
Polymer-electrodes for detecting nucleic acid hybridization and method of use thereof
|
US20010011075A1
(en)
|
1999-02-05 |
2001-08-02 |
Leroy B Townsend |
5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
|
WO2002096927A2
(en)
|
2001-05-29 |
2002-12-05 |
Ribozyme Pharmaceuticals, Incorporated |
Ribozyme based treatment of female reproductive diseases
|
AU1430097A
(en)
|
1996-01-16 |
1997-08-11 |
Ribozyme Pharmaceuticals, Inc. |
Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
|
US5767097A
(en)
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
EP0799834A1
(en)
|
1996-04-04 |
1997-10-08 |
Novartis AG |
Modified nucleotides
|
US20040171032A1
(en)
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20040171028A1
(en)
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20050042647A1
(en)
|
1996-06-06 |
2005-02-24 |
Baker Brenda F. |
Phosphorous-linked oligomeric compounds and their use in gene modulation
|
US20050032067A1
(en)
|
2002-11-05 |
2005-02-10 |
Prakash Thazha P. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
WO1998000434A1
(en)
|
1996-06-28 |
1998-01-08 |
Novartis Ag |
Modified oligonucleotides
|
CZ120699A3
(cs)
|
1996-10-16 |
1999-09-15 |
Icn Pharmaceuticals, Inc. |
Monocyklická L-nukleosidová analoga a jejich využití
|
NZ505531A
(en)
|
1996-10-16 |
2001-08-31 |
Icn Pharmaceuticals |
7-Propyl-8-oxo-alpha or beta-L-guanine alpha or beta-L-nucleoside
|
NZ507848A
(en)
|
1996-10-28 |
2005-01-28 |
Univ Washington |
Method of increasing the mutation rate of a virus in a non-human by administering an RNA nucleoside analogue to a virally infected cell
|
US6887707B2
(en)
|
1996-10-28 |
2005-05-03 |
University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
US20030144489A1
(en)
|
1997-06-09 |
2003-07-31 |
Alex Burgin |
Method for screening nucleic acid catalysts
|
AU9210498A
(en)
|
1997-08-29 |
1999-03-16 |
Gilead Sciences, Inc. |
5',5'-linked oligomers having anti-thrombin activity
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
US6232463B1
(en)
|
1997-10-09 |
2001-05-15 |
Isis Pharmaceuticals, Inc. |
Substituted purines and oligonucleotide cross-linking
|
US6703374B1
(en)
|
1997-10-30 |
2004-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleosides for imaging and treatment applications
|
US20030004122A1
(en)
|
1997-11-05 |
2003-01-02 |
Leonid Beigelman |
Nucleotide triphosphates and their incorporation into oligonucleotides
|
US6528640B1
(en)
|
1997-11-05 |
2003-03-04 |
Ribozyme Pharmaceuticals, Incorporated |
Synthetic ribonucleic acids with RNAse activity
|
US6482932B1
(en)
|
1997-11-05 |
2002-11-19 |
Ribozyme Pharmaceuticals, Incorporated |
Nucleoside triphosphates and their incorporation into oligonucleotides
|
US6617438B1
(en)
|
1997-11-05 |
2003-09-09 |
Sirna Therapeutics, Inc. |
Oligoribonucleotides with enzymatic activity
|
US6015703A
(en)
|
1998-03-10 |
2000-01-18 |
Iogen Corporation |
Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase
|
JP2002512794A
(ja)
|
1998-04-29 |
2002-05-08 |
リボザイム・ファーマシューティカルズ・インコーポレーテッド |
ヌクレオチド三リン酸およびリボザイム内へのそれらの取り込み
|
US6030957A
(en)
|
1998-06-29 |
2000-02-29 |
Wayne Hughes Institute |
Aryl phosphate derivatives of d4T having anti-HIV activity
|
US7091315B1
(en)
|
1998-07-15 |
2006-08-15 |
Human Genome Sciences, Inc. |
Protein HDPBQ71
|
WO2000014263A2
(en)
|
1998-09-03 |
2000-03-16 |
Board Of Regents, The University Of Texas System |
Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
|
US6566059B1
(en)
|
1998-10-01 |
2003-05-20 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6440705B1
(en)
|
1998-10-01 |
2002-08-27 |
Vincent P. Stanton, Jr. |
Method for analyzing polynucleotides
|
US6458945B1
(en)
|
1998-10-01 |
2002-10-01 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
CA2252144A1
(en)
|
1998-10-16 |
2000-04-16 |
University Of Alberta |
Dual action anticancer prodrugs
|
US7064114B2
(en)
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
CA2367266A1
(en)
|
1999-03-19 |
2000-09-28 |
Mingshu Li |
Gel-microemulsion formulations
|
US6569630B1
(en)
|
1999-07-02 |
2003-05-27 |
Conceptual Mindworks, Inc. |
Methods and compositions for aptamers against anthrax
|
US20040023265A1
(en)
|
1999-07-02 |
2004-02-05 |
Jeevalatha Vivekananda |
Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin
|
WO2001009318A1
(fr)
|
1999-07-29 |
2001-02-08 |
Helix Research Institute |
Genes associes au cancer du foie
|
US6831069B2
(en)
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
CN1384834A
(zh)
|
1999-08-27 |
2002-12-11 |
Icn药品公司 |
吡咯并[2,3-d]嘧啶核苷类似物
|
US6649750B1
(en)
|
2000-01-05 |
2003-11-18 |
Isis Pharmaceuticals, Inc. |
Process for the preparation of oligonucleotide compounds
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
EP1296690A2
(en)
|
2000-02-18 |
2003-04-02 |
Shire Biochem Inc. |
METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS USING NUCLEOSIDE ANALOGUES
|
US7235649B2
(en)
|
2000-03-24 |
2007-06-26 |
Duke University |
Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
|
WO2001072779A1
(en)
|
2000-03-24 |
2001-10-04 |
Duke University |
Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
|
US20020127598A1
(en)
|
2000-03-27 |
2002-09-12 |
Wenqiang Zhou |
Solution-phase combinatorial library synthesis and pharmaceutically active compounds produced thereby
|
FR2808797A1
(fr)
|
2000-05-09 |
2001-11-16 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'uridine, leur procede de preparation et leur application comme medicaments
|
WO2001090304A2
(en)
|
2000-05-19 |
2001-11-29 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
NZ547204A
(en)
|
2000-05-26 |
2008-01-31 |
Idenix Cayman Ltd |
Methods and compositions for treating flaviviruses and pestiviruses
|
AU2001265296A1
(en)
|
2000-05-26 |
2001-12-11 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
ES2227203T3
(es)
|
2000-05-26 |
2005-04-01 |
Idenix (Cayman) Limited |
Metodos para tratar la infeccion por el virus de la hepatitis delta con beta-1-2'-desoxinucleosidos.
|
US6974667B2
(en)
|
2000-06-14 |
2005-12-13 |
Gene Logic, Inc. |
Gene expression profiles in liver cancer
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
KR101155294B1
(ko)
|
2000-06-16 |
2013-03-07 |
캠브리지 안티바디 테크놀로지 리미티드 |
면역특이적으로 BLyS에 결합하는 항체
|
US20030207271A1
(en)
|
2000-06-30 |
2003-11-06 |
Holwitt Eric A. |
Methods and compositions for biological sensors
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
US20030166064A1
(en)
|
2000-08-03 |
2003-09-04 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
EP1346040A2
(en)
|
2000-09-11 |
2003-09-24 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
AU2001296301A8
(en)
|
2000-09-26 |
2009-07-30 |
Human Genome Sciences Inc |
Nucleic acids, proteins, and antibodies
|
CN1133642C
(zh)
|
2000-10-09 |
2004-01-07 |
清华大学 |
核苷5’-硫代磷酰氨基酸酯化合物
|
EP1360325A2
(en)
|
2000-10-18 |
2003-11-12 |
Pharmasset Limited |
Multiplex quantification of nucleic acids in diseased cells
|
WO2002058534A2
(en)
|
2000-11-20 |
2002-08-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
GEP20053601B
(en)
|
2001-01-22 |
2005-08-10 |
Merck & Co Inc |
Nucleoside Derivatives as Inhibitors of RNA-Dependent RNA Viral Polymerase
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
US20030073144A1
(en)
|
2001-01-30 |
2003-04-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of pancreatic cancer
|
WO2002069903A2
(en)
|
2001-03-06 |
2002-09-12 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
AU2002324424A1
(en)
|
2001-03-21 |
2002-12-03 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
CA2447183A1
(en)
|
2001-03-28 |
2002-10-10 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
US6995148B2
(en)
|
2001-04-05 |
2006-02-07 |
University Of Pittsburgh |
Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy
|
CN1186456C
(zh)
|
2001-04-30 |
2005-01-26 |
曹卫 |
通用模板核酸检测方法和试剂盒
|
WO2002092006A2
(en)
|
2001-05-16 |
2002-11-21 |
Micrologix Biotech, Inc. |
Nucleic acid-based compounds and methods of use thereof
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
AU2002324700A1
(en)
|
2001-08-14 |
2003-03-03 |
Bayer Ag |
Nucleic acid and amino acid sequences involved in pain
|
WO2003016497A2
(en)
|
2001-08-17 |
2003-02-27 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
WO2003016572A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Oligonucleotide therapeutics for treating hepatitis c virus infections
|
CN1159332C
(zh)
|
2001-08-24 |
2004-07-28 |
清华大学 |
一种硫代磷酰氨基酸酯化合物及其制备方法
|
CN1133641C
(zh)
|
2001-08-24 |
2004-01-07 |
清华大学 |
一种含有3'叠氮胸苷的硫代磷酰氨基酸酯化合物及其制备方法
|
CN1186457C
(zh)
|
2001-08-29 |
2005-01-26 |
曹卫 |
均相基因矩阵
|
AU2002343417A1
(en)
|
2001-09-24 |
2003-04-14 |
Nuvelo |
Novel nucleic acids and polypeptides
|
JP2005525788A
(ja)
|
2001-09-28 |
2005-09-02 |
インサイト・ゲノミックス・インコーポレイテッド |
酵素
|
MXPA04003451A
(es)
|
2001-10-09 |
2005-02-17 |
Dimensional Pharm Inc |
Difeniloxazoles substituidos, la sintesis de los mismos y el uso de los mismo como detectores fluorescencia.
|
US20050186568A1
(en)
|
2001-10-19 |
2005-08-25 |
Olga Bandman |
Kinases and phosphatases
|
US7037718B2
(en)
|
2001-10-26 |
2006-05-02 |
Cornell Research Foundation, Inc. |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
|
US7488598B2
(en)
|
2001-10-26 |
2009-02-10 |
Cornell Center For Technology Enterprise And Commercialization |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
|
EP1497315A2
(en)
|
2001-10-29 |
2005-01-19 |
Incyte Genomics, Inc. |
Nucleic acid-associated proteins
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
EP1504101A2
(en)
|
2001-11-09 |
2005-02-09 |
Incyte Genomics, Inc. |
Intracellular signaling molecules
|
EP1504099A4
(en)
|
2001-12-10 |
2006-05-10 |
Nuvelo Inc |
NEW NUCLEIC ACIDS AND POLYPEPTIDES
|
WO2003051896A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Cytidine libraries and compounds synthesized by solid-phase combinatorial strategies
|
WO2003054219A2
(en)
|
2001-12-19 |
2003-07-03 |
Incyte Corporation |
Nucleic acid-associated proteins
|
WO2003072602A2
(en)
|
2001-12-20 |
2003-09-04 |
Cellzome Ag |
Protein complexes and methods for their use
|
WO2003062376A2
(en)
|
2002-01-16 |
2003-07-31 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
AU2003205174A1
(en)
|
2002-01-17 |
2003-09-02 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
WO2003062255A2
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
WO2003062391A2
(en)
|
2002-01-18 |
2003-07-31 |
Incyte Corporation |
Structural and cytoskeleton-associated proteins
|
AU2003205353A1
(en)
|
2002-01-25 |
2003-09-02 |
Incyte Genomics, Inc. |
Protein modification and maintenance molecules
|
US20050042632A1
(en)
|
2002-02-13 |
2005-02-24 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for nucleic acids
|
US20080207542A1
(en)
|
2002-03-26 |
2008-08-28 |
Sirna Therapeutics, Inc. |
RNA inteference mediated inhibition of hepatitis C virus (HVC) gene expression using short interfering nucleic acid (siNA)
|
WO2003072729A2
(en)
|
2002-02-22 |
2003-09-04 |
Incyte Corporation |
Enzymes
|
US7285658B2
(en)
|
2002-02-28 |
2007-10-23 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
ATE408711T1
(de)
|
2002-03-01 |
2008-10-15 |
Integrated Dna Tech Inc |
Polynomiale amplifikation von nukleinsäuren
|
WO2003076586A2
(en)
|
2002-03-06 |
2003-09-18 |
Incyte Corporation |
Nucleic acid-associated proteins
|
AU2003218238A1
(en)
|
2002-03-15 |
2003-09-29 |
Incyte Corporation |
Proteins associated with growth, differentiation, and death
|
WO2003083085A2
(en)
|
2002-03-28 |
2003-10-09 |
Incyte Corporation |
Transporters and ion channels
|
AU2003220607A1
(en)
|
2002-03-29 |
2003-10-13 |
Incyte Corporation |
Enzymes
|
AU2003231981A1
(en)
|
2002-03-29 |
2003-10-13 |
Incyte Corporation |
Protein modification and maintenance molecules
|
AU2003222189A1
(en)
|
2002-04-05 |
2003-10-27 |
Incyte Corporation |
Secreted proteins
|
US20030190626A1
(en)
|
2002-04-09 |
2003-10-09 |
Vasulinga Ravikumar |
Phosphorothioate monoester modified oligomers
|
US20060074035A1
(en)
|
2002-04-17 |
2006-04-06 |
Zhi Hong |
Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections
|
WO2003090674A2
(en)
|
2002-04-23 |
2003-11-06 |
Viropharma Incorporated |
Compounds, compositions and methods for treating or preventing viral infections and associated diseases
|
WO2003093439A2
(en)
|
2002-04-29 |
2003-11-13 |
Incyte Corporation |
Enzymes
|
AU2003232071A1
(en)
|
2002-05-06 |
2003-11-17 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis c virus infection
|
WO2003094848A2
(en)
|
2002-05-10 |
2003-11-20 |
Incyte Corporation |
Nucleic acid-associated proteins
|
FR2840318B1
(fr)
|
2002-05-29 |
2004-12-03 |
Quoc Kiet Pham |
Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
|
CA2488611C
(en)
|
2002-06-07 |
2011-11-15 |
Kylix, B.V. |
Compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
|
AU2003245627A1
(en)
|
2002-06-21 |
2004-01-06 |
Incyte Corporation |
Kinases and phosphatases
|
NZ537662A
(en)
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
AU2003245747A1
(en)
|
2002-06-28 |
2004-01-19 |
Incyte Corporation |
Enzymes
|
AU2003248748A1
(en)
|
2002-06-28 |
2004-01-19 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
RS114104A
(en)
|
2002-06-28 |
2007-02-05 |
Idenix (Cayman) Limited, |
2' and 3'-nucleoside prodrugs for treating flaviviridae infections
|
WO2004009797A2
(en)
|
2002-07-23 |
2004-01-29 |
Incyte Corporation |
Protein modification and maintenance molecules
|
WO2004014312A2
(en)
|
2002-08-08 |
2004-02-19 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
GB0221694D0
(en)
|
2002-09-18 |
2002-10-30 |
Glaxo Group Ltd |
Compounds
|
US20070207973A1
(en)
|
2002-09-24 |
2007-09-06 |
Koronis Pharmaceuticals, Incorporated |
1,3,5-Triazines for Treatment of Viral Diseases
|
CA2499036A1
(en)
|
2002-09-24 |
2004-04-08 |
Koronis Pharmaceuticals, Incorporated |
1,3,5-triazines for treatment of viral diseases
|
SI1576138T1
(sl)
|
2002-11-15 |
2017-07-31 |
Idenix Pharmaceuticals Llc |
2'-metil nukleozidi v kombinaciji z interferon in flaviviridae mutacijo
|
US20050037394A1
(en)
|
2002-12-03 |
2005-02-17 |
Keefe Anthony D. |
Method for in vitro selection of 2'-substituted nucleic acids
|
AU2003297682A1
(en)
|
2002-12-03 |
2004-06-23 |
Archemix Corporation |
Method for in vitro selection of 2'-substituted nucleic acids
|
PL377287A1
(pl)
|
2002-12-12 |
2006-01-23 |
Idenix (Cayman) Limited |
Sposób wytwarzania 2'-rozgałęzionych nukleozydów
|
ATE442376T1
(de)
|
2002-12-23 |
2009-09-15 |
Dynavax Tech Corp |
Oligonukleotide mit einer immunsystemstimulierenden sequenz und verfahren zu deren anwendung
|
AR043006A1
(es)
|
2003-02-12 |
2005-07-13 |
Merck & Co Inc |
Proceso para preparar ribonucleosidos ramificados
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
US20050261237A1
(en)
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
WO2004096287A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
MXPA05011297A
(es)
|
2003-04-25 |
2006-05-25 |
Gilead Sciences Inc |
Analogos antivirales de fosfonato.
|
US20090247488A1
(en)
|
2003-04-25 |
2009-10-01 |
Carina Cannizzaro |
Anti-inflammatory phosphonate compounds
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
CN101410120A
(zh)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
UA82695C2
(uk)
|
2003-06-06 |
2008-05-12 |
Нисан Кемикал Индастриз, Лтд. |
Гетероароматичні сполуки як активатори рецептора тромбопоетину
|
US20070203083A1
(en)
|
2003-06-13 |
2007-08-30 |
Mootha Vamsi K |
Methods Of Regulating Metabolism And Mitochondrial Function
|
CN100510101C
(zh)
|
2003-07-14 |
2009-07-08 |
博奥生物有限公司 |
用于检测sars病毒和其它感染性物质的方法和组合物
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
AU2004269026B2
(en)
|
2003-08-27 |
2010-02-25 |
Biota Scientific Management Pty Ltd |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
GB2422782A
(en)
|
2003-10-21 |
2006-08-09 |
Inspire Pharmaceuticals Inc |
Non-nucleotide compositions and method for treating pain
|
US7368438B2
(en)
|
2003-10-21 |
2008-05-06 |
Inspire Pharmaceuticals, Inc. |
Non-nucleotide compositions and method for inhibiting platelet aggregation
|
US7504497B2
(en)
|
2003-10-21 |
2009-03-17 |
Inspire Pharmaceuticals, Inc. |
Orally bioavailable compounds and methods for inhibiting platelet aggregation
|
US7749981B2
(en)
|
2003-10-21 |
2010-07-06 |
Inspire Pharmaceuticals, Inc. |
Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
|
US7335648B2
(en)
|
2003-10-21 |
2008-02-26 |
Inspire Pharmaceuticals, Inc. |
Non-nucleotide composition and method for inhibiting platelet aggregation
|
US20050239733A1
(en)
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
JP2005162732A
(ja)
|
2003-11-13 |
2005-06-23 |
Bayer Cropscience Ag |
殺虫性ニコチノイルカーバメート類
|
WO2005053603A2
(en)
|
2003-12-08 |
2005-06-16 |
Yeda Research And Development Co. Ltd. |
Antigen receptor variable region typing
|
WO2005077966A1
(en)
|
2004-02-10 |
2005-08-25 |
Isis Pharmaceuticals, Inc. |
Substituted pixyl protecting groups for oligonucleotide synthesis
|
WO2005097993A2
(en)
|
2004-02-19 |
2005-10-20 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory viral rna oligonucleotides
|
US8759317B2
(en)
|
2004-03-18 |
2014-06-24 |
University Of South Florida |
Method of treatment of cancer using guanosine 3′, 5′ cyclic monophosphate (cyclic GMP)
|
EP1765847A4
(en)
|
2004-05-27 |
2010-10-20 |
Alnylam Pharmaceuticals Inc |
NUCLEASERESISTENT DOUBLE-STRANDED RIBONUCLEIC ACID
|
GB0413726D0
(en)
|
2004-06-18 |
2004-07-21 |
Lauras As |
Compounds
|
WO2006088490A2
(en)
|
2004-06-30 |
2006-08-24 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a non-phosphate backbone linkage
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
CN101044151B
(zh)
|
2004-08-23 |
2011-01-19 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-叠氮基-核苷
|
DK1794174T3
(da)
|
2004-09-01 |
2012-07-09 |
Dynavax Tech Corp |
Fremgangsmåder og sammensætninger til hæmning af medfødte immunresponser og autoimmunitet
|
EP1809301B1
(en)
|
2004-09-14 |
2019-11-06 |
Gilead Pharmasset LLC |
2-fluoro-2-alkyl-substituted d-ribonolactone intermediates
|
US7553653B2
(en)
|
2004-09-17 |
2009-06-30 |
Biomarin Pharmaceutical Inc. |
Variants and chemically-modified variants of phenylalanine ammonia-lyase
|
AU2005289588B2
(en)
|
2004-09-24 |
2011-12-22 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of ApoB and uses thereof
|
WO2006038865A1
(en)
|
2004-10-01 |
2006-04-13 |
Betagenon Ab |
Nucleotide derivatives for the treatment of type 2 diabetes and other disorders
|
KR101215225B1
(ko)
|
2004-12-08 |
2012-12-26 |
닛산 가가쿠 고교 가부시키 가이샤 |
트롬보포이에틴 수용체 활성화제로서의3-에틸리덴히드라지노 치환 헤테로시클릭 화합물
|
EP1819365B1
(en)
|
2004-12-09 |
2014-07-02 |
Alnylam Pharmaceuticals Inc. |
Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs
|
JP2008524237A
(ja)
|
2004-12-17 |
2008-07-10 |
ダイナバックス テクノロジーズ コーポレイション |
免疫寛容の誘導又は促進のための方法及び組成物
|
EP1824482B1
(en)
|
2004-12-17 |
2014-02-12 |
Anadys Pharmaceuticals, Inc. |
3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
|
US20070066552A1
(en)
|
2005-01-21 |
2007-03-22 |
Introgen Therapeutics, Inc. |
Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
|
AU2006222563A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
WO2006096769A2
(en)
|
2005-03-08 |
2006-09-14 |
Intermune, Inc. |
Use of alpha-glucosidase inhibitors to treat alphavirus infections
|
JP2006248949A
(ja)
|
2005-03-09 |
2006-09-21 |
Univ Nagoya |
ヌクレオシド誘導体、ヌクレオチド誘導体及びそれらの製造方法
|
JP2006248975A
(ja)
|
2005-03-10 |
2006-09-21 |
Tokyo Institute Of Technology |
ヌクレオシドホスホロアミダイト化合物
|
WO2006105440A2
(en)
|
2005-03-30 |
2006-10-05 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
ES2261072B1
(es)
|
2005-04-06 |
2007-12-16 |
Consejo Superior Investig. Cientificas |
Fosforotioatos derivados de analogos a nucleosido para terapia antirretroviral.
|
US20060240462A1
(en)
|
2005-04-21 |
2006-10-26 |
Johnson & Johnson Research Pty Limited |
Methods for amplification and detection of nucleic acids
|
EP1876894A1
(en)
|
2005-04-26 |
2008-01-16 |
The Board of Trustees of the University of Illinois |
Nucleoside compounds and methods of use thereof
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
WO2007027248A2
(en)
|
2005-05-16 |
2007-03-08 |
Valeant Research & Development |
3', 5' - cyclic nucleoside analogues for treatment of hcv
|
WO2006130781A2
(en)
|
2005-06-01 |
2006-12-07 |
The Scripps Research Institute |
Crystal of a cytochrome-ligand complex and methods of use
|
WO2007006544A2
(en)
|
2005-07-12 |
2007-01-18 |
Vrije Universiteit Brussel |
Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
|
EP2311795A3
(en)
|
2005-07-21 |
2011-12-28 |
Nereus Pharmaceuticals, Inc. |
Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
WO2007020018A1
(en)
|
2005-08-12 |
2007-02-22 |
Universite Libre De Bruxelles |
Use of purinergic and pyrimidinergic receptor agonists for dendritic cells based immunotherapies
|
EP1928237A4
(en)
|
2005-09-02 |
2011-03-09 |
Abbott Lab |
NEW HETEROCYCLES BASED ON IMIDAZO
|
DK2385141T3
(da)
|
2005-10-07 |
2013-10-28 |
Speedx Pty Ltd |
Flerkomponentnukleinsyreenzymer og fremgangsmåder til anvendelse heraf
|
JP5336853B2
(ja)
|
2005-11-02 |
2013-11-06 |
プロチバ バイオセラピューティクス インコーポレイティッド |
修飾siRNA分子およびその使用法
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
CA2626584A1
(en)
|
2005-11-04 |
2007-05-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of nav1.8 gene
|
EP1974732A4
(en)
|
2005-11-24 |
2010-08-11 |
Univ Hokkaido Nat Univ Corp |
THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE
|
NZ568909A
(en)
|
2005-12-09 |
2011-10-28 |
Hoffmann La Roche |
Antiviral 4-fluoro-4-methyl nucleoside prodrugs
|
WO2007073489A2
(en)
|
2005-12-22 |
2007-06-28 |
Trustees Of Boston University |
Molecules for gene delivery and gene therapy, and methods of use thereof
|
AU2007209977A1
(en)
|
2006-01-27 |
2007-08-09 |
George Mason Intellectual Properties, Inc. |
Ocular fluid markers
|
US7846908B2
(en)
|
2006-03-16 |
2010-12-07 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of TGF-beta and therapeutic uses thereof
|
WO2007115168A2
(en)
|
2006-03-31 |
2007-10-11 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of eg5 gene
|
FR2900334B1
(fr)
|
2006-04-28 |
2008-06-27 |
Oreal |
Procede de depigmentation de la peau
|
ES2600792T3
(es)
|
2006-05-03 |
2017-02-10 |
Chimerix, Inc. |
Alcoxialquilésteres metabólicamente estables de fosfonatos, fosfonatos nucleosídicos y fosfatos nucleosídicos antivirales o antiproliferativos
|
WO2007149554A2
(en)
|
2006-06-22 |
2007-12-27 |
The Johns Hopkins University |
Methods for restoring neural function
|
US8470522B2
(en)
|
2006-07-20 |
2013-06-25 |
Kaohsiung Medical University |
Three-dimensional culture containing human articular chondrocytes with induced terminal differentiation changes and preparation process and uses of the same
|
AU2007300663A1
(en)
|
2006-07-21 |
2008-04-03 |
Pharmexa Inc. |
Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
|
WO2008024977A2
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Isoquinoline, quinazoline and phthalazine derivatives
|
CA2661873A1
(en)
|
2006-08-31 |
2008-03-06 |
Abbott Laboratories |
Cytochrome p450 oxidase inhibitors and uses thereof
|
WO2008033432A2
(en)
|
2006-09-12 |
2008-03-20 |
Coley Pharmaceutical Group, Inc. |
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
|
US20080161324A1
(en)
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
GB0618235D0
(en)
|
2006-09-15 |
2006-10-25 |
Lauras As |
Process
|
EP2084175B1
(en)
|
2006-10-10 |
2010-12-29 |
Medivir AB |
Hcv nucleoside inhibitor
|
PL216525B1
(pl)
|
2006-10-17 |
2014-04-30 |
Ct Badań Molekularnych I Makromolekularnych Polskiej Akademii Nauk |
5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
US8252757B2
(en)
|
2006-11-09 |
2012-08-28 |
Dynavax Technologies Corporation |
Long term disease modification using immunostimulatory oligonucleotides
|
WO2008064304A2
(en)
|
2006-11-22 |
2008-05-29 |
Trana Discovery, Inc. |
Compositions and methods for the identification of inhibitors of protein synthesis
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
JP2010515680A
(ja)
|
2007-01-05 |
2010-05-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Rna依存性rnaウイルス感染症の治療用としてのヌクレオシドアリールホスホロアミデート
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
CN101652378A
(zh)
|
2007-01-31 |
2010-02-17 |
艾丽奥斯生物制药有限公司 |
2-5a衍生物及其作为抗癌剂、抗病毒剂和抗寄生虫剂的用途
|
US20100190837A1
(en)
|
2007-02-15 |
2010-07-29 |
Isis Pharmaceuticals, Inc. |
5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
|
WO2008103276A2
(en)
|
2007-02-16 |
2008-08-28 |
Merck & Co., Inc. |
Compositions and methods for potentiated activity of biologicaly active molecules
|
US8242087B2
(en)
|
2007-02-27 |
2012-08-14 |
K.U.Leuven Research & Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
EP2144921A2
(en)
|
2007-02-27 |
2010-01-20 |
K.U. Leuven Research and Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
MX2009009530A
(es)
|
2007-03-07 |
2010-05-19 |
Nventa Biopharmaceuticals Corp |
Composiciones de acidos nucleicos cerrados bicatenarios.
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
GB0709791D0
(en)
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
PL211703B1
(pl)
|
2007-07-03 |
2012-06-29 |
Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk |
Tiohypofosforanowe i ditiohypofosforanowe analogi 5'-O-hypofosforanów nukleozydów i ich estry alkilowe oraz sposób ich wytwarzania
|
CN101108870A
(zh)
|
2007-08-03 |
2008-01-23 |
冷一欣 |
核苷磷酸酯类化合物及制备方法和应用
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
BRPI0821106A2
(pt)
|
2007-11-29 |
2015-06-16 |
Ligand Pharm Inc |
Pró-fármacos de nucleosídeo e usos dos mesmos
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
WO2009086201A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents
|
CA2722308C
(en)
|
2008-04-15 |
2024-02-27 |
Rfs Pharma, Llc. |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
CN102186497B
(zh)
|
2008-08-15 |
2015-02-25 |
Uab研究基金会 |
嘌呤核苷磷酸化酶作为核苷前体药物的酶激活剂
|
GB0815315D0
(en)
|
2008-08-21 |
2008-09-24 |
Univ Leiden |
Organ protection
|
AU2009308217B2
(en)
|
2008-10-24 |
2016-01-21 |
Ionis Pharmaceuticals, Inc. |
5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
|
WO2010091386A2
(en)
|
2009-02-06 |
2010-08-12 |
Rfs Pharma, Llc |
Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
|
CN102421293A
(zh)
|
2009-03-20 |
2012-04-18 |
艾丽奥斯生物制药有限公司 |
取代的核苷和核苷酸类似物
|
JO3027B1
(ar)
*
|
2009-05-14 |
2016-09-05 |
Janssen Products Lp |
نيوكليوسيدات يوراسيل سبيرواوكسيتان
|
US20100297079A1
(en)
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
WO2011005595A2
(en)
|
2009-06-24 |
2011-01-13 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
CN102844030A
(zh)
|
2010-01-29 |
2012-12-26 |
沃泰克斯药物股份有限公司 |
用于治疗丙型肝炎病毒感染的疗法
|
AR094621A1
(es)
*
|
2010-04-01 |
2015-08-19 |
Idenix Pharmaceuticals Inc |
Compuestos y composiciones farmacéuticas para el tratamiento de infecciones virales
|
US20110306541A1
(en)
|
2010-06-10 |
2011-12-15 |
Gilead Sciences, Inc. |
Methods for treating hcv
|
WO2012040126A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
US8877731B2
(en)
|
2010-09-22 |
2014-11-04 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
JP6012605B2
(ja)
|
2010-09-22 |
2016-10-25 |
アリオス バイオファーマ インク. |
置換されたヌクレオチドアナログ
|
CA2819041A1
(en)
|
2010-12-22 |
2012-06-28 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
PE20140522A1
(es)
|
2011-04-13 |
2014-05-03 |
Merck Sharp & Dohme |
Derivados de nucleosidos 2'- sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
CA2860234A1
(en)
|
2011-12-22 |
2013-06-27 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
SG11201402826YA
(en)
|
2011-12-22 |
2014-12-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
NZ631601A
(en)
|
2012-03-21 |
2016-06-24 |
Alios Biopharma Inc |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
NZ630800A
(en)
|
2012-03-21 |
2016-06-24 |
Alios Biopharma Inc |
Methods of preparing substituted nucleotide analogs
|
KR102172040B1
(ko)
|
2012-03-21 |
2020-10-30 |
얀센 바이오파마, 인코퍼레이트. |
치환된 뉴클레오사이드, 뉴클레오타이드 및 그의 유사체
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
EP2827876A4
(en)
|
2012-03-22 |
2015-10-28 |
Alios Biopharma Inc |
PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG
|
WO2014100498A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
CN110684067A
(zh)
|
2012-12-21 |
2020-01-14 |
艾丽奥斯生物制药有限公司 |
取代的核苷和核苷酸
|
WO2014134251A1
(en)
|
2013-02-28 |
2014-09-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
WO2014164533A1
(en)
|
2013-03-11 |
2014-10-09 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
CA2908313A1
(en)
|
2013-04-05 |
2014-10-09 |
Alios Biopharma, Inc. |
Hepatitis c viral infection treatment using a combination of compounds
|
ES2825035T3
(es)
|
2013-06-26 |
2021-05-14 |
Janssen Biopharma Inc |
Nucleósidos, nucleótidos y análogos de estos sustituidos con 4-azidoalquilo
|
US9815864B2
(en)
|
2013-06-26 |
2017-11-14 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
SG10201804835VA
(en)
|
2013-10-11 |
2018-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
CA3207106A1
(en)
|
2014-06-24 |
2015-12-30 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
MX2016017382A
(es)
|
2014-06-24 |
2017-04-27 |
Alios Biopharma Inc |
Metodos para preparar analogos de nucleotido sustituidos.
|
AU2015280234B2
(en)
|
2014-06-24 |
2021-04-01 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
AU2015294343A1
(en)
|
2014-07-22 |
2017-02-02 |
Alios Biopharma, Inc. |
Methods for treating paramyxoviruses
|
SG10201901010PA
(en)
|
2014-08-05 |
2019-03-28 |
Alios Biopharma Inc |
Combination therapy for treating a paramyxovirus
|
WO2016069489A1
(en)
|
2014-10-28 |
2016-05-06 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleoside analogs
|